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SUMMARY
Weighting methods offer an approach to estimating causal treatment effects in observational
studies. However, if weights are estimated by maximum likelihood, misspeciﬁcation of the treat-
ment assignment model can lead to weighted estimators with substantial bias and variance. In
this paper, we propose a uniﬁed framework for constructing weights such that a set of measured
pretreatment covariates is unassociated with treatment assignment after weighting. We derive
conditions for weight estimation by eliminating the associations between these covariates and
treatment assignment characterized in a chosen treatment assignment model after weighting. The
moment conditions in covariate balancing weight methods for binary, categorical and continuous
treatments in cross-sectional settings are special cases of the conditions in our framework, which
extends to longitudinal settings. Simulation shows that our method gives treatment effect esti-
mates with smaller biases and variances than the maximum likelihood approach under treatment
assignment model misspeciﬁcation. We illustrate our method with an application to systemic
lupus erythematosus data.
Some key words: Causal inference; Confounding; Continuous treatment; Covariate balance; Inverse probability
weighting; Propensity function.
1. INTRODUCTION
Weighting methods are widely used to estimate causal treatment effects. The propensity func-
tion, the conditional probability of receiving treatment given a set of measured pretreatment
covariates (Imai & van Dyk, 2004), features prominently in weighting methods.A natural choice
of weights is a ratio of the marginal probability of treatment assignment and the propensity func-
tion, henceforth referred to as the stabilized inverse probability of treatment weights (Robins,
2000; Robins et al., 2000). Despite the appeal of weighting methods, problems arise when the
propensity function is unknown. Hence weights are usually constructed using the stabilized
inverse probability of treatment weight structure with an estimated propensity function, often
obtained by maximum likelihood (Imbens, 2000; Robins et al., 2000), although other methods
have been proposed (Lee et al., 2010). However, because these estimation procedures do not
directly aim at the goal of weighting, which is to eliminate the association between a set of
measured pretreatment covariates satisfying the conditions in § 2·1 and treatment assignment
after weighting, a slightly misspeciﬁed propensity function model can result in badly biased
treatment effect estimates (Kang & Schafer, 2007). Recently, this problem has motivated new
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weighting methods that optimize covariate balance, the covariate balancing weights (Graham
et al., 2012; Hainmueller, 2012; McCaffrey et al., 2013; Imai & Ratkovic, 2014, 2015; Zhu et al.,
2015; Zubizarreta, 2015; Chan et al., 2016; Fong et al., 2018). These weights can dramatically
improve the performance of weighting methods, but there is a lack of a framework to generalize
them to complex treatment types, such as semicontinuous or multivariate treatments, and even to
longitudinal settings.
In this paper, we introduce covariate association eliminating weights, a uniﬁed framework
for constructing weights with the goal being that a set of measured pretreatment covariates
will be unassociated with treatment assignment after weighting. Our method can be used to
estimate causal effects for semicontinuous, count, ordinal, or even multivariate treatments, and
it extends to longitudinal settings. An example of estimating the direct effect of a time-varying
treatment on a longitudinal outcome is provided in § 8. Utilizing the generality of the propensity
function and its capacity to characterize covariate associations with treatment assignment, we
derive conditions forweight estimation by eliminating the association between the set ofmeasured
pretreatment covariates and treatment assignment speciﬁed in a chosen propensity functionmodel
after weighting, i.e., by solving the weighted score equations of the propensity function model at
parameter values which indicate that the covariates are unassociated with treatment assignment.
Our method has several attractive characteristics. First, it encompasses existing covariate bal-
ancing weight methods and provides a uniﬁed framework for weighting with treatments of any
distribution; see § 4. By eliminating the associations between the covariates and treatment assign-
ment after weighting, our method can provide some robustness against misspeciﬁcation of the
functional forms of the covariates in a propensity function model, particularly if they are pre-
dictive of the outcome; see § 6. Second, it is clear from our framework what type of covariate
associations are eliminated after weighting. For example, the covariate balancing weight method
proposed in Fong et al. (2018) will only eliminate the associations between the covariates and
the mean of a continuous treatment; see § 4·2. Our method can also eliminate the associations
between the covariates and the variance of the continuous treatment. Third, our method extends
to longitudinal settings; see § 8. In particular, apart from handling treatments of any distribution,
it can accommodate unbalanced observation schemes and can incorporate a variety of stabilized
weight structures. In contrast, to the best of our knowledge, the only available covariate balancing
weight method for longitudinal settings, proposed by Imai & Ratkovic (2015), focuses on binary
treatments in a balanced observation scheme, and it is not clear how to incorporate arbitrary stabi-
lized weight structures in their approach. Finally, our method can be implemented with standard
statistical software by solving a convex optimization problem that identiﬁes minimum-variance
weights subject to our conditions (Zubizarreta, 2015). This is especially appealing for nonbinary
treatments with outliers (Naimi et al., 2014), because it protects against extreme weights which
often lead to unstable treatment effect estimates in practice.
2. THE PROPENSITY FUNCTION
2·1. Deﬁnition and assumptions
Let Xi, Ti and Yi be respectively a set of measured pretreatment covariates, the possibly
multivariate treatment variable and the outcome for the ith unit (i = 1, . . . , n) in a simple random
sample of size n. Following Imai & van Dyk (2004), we deﬁne the propensity function as the
conditional probability of treatment given the set ofmeasured pretreatment covariates, i.e., pr(Ti |
Xi;βtrue), where βtrue parameterizes this distribution. The parameter βtrue is assumed to be unique
and ﬁnite-dimensional, and is such that pr(Ti | Xi) depends on Xi only through a subset of βtrue;
Downloaded from https://academic.oup.com/biomet/advance-article-abstract/doi/10.1093/biomet/asy015/4986429
by University of Cambridge user
on 05 June 2018
Uniﬁed weighting framework for causal effect estimation 3
this is the uniquely parameterized propensity function assumption of Imai & van Dyk (2004).
For example, if pr(Ti | Xi) follows a regression model, then βtrue would include regression
coefﬁcients that characterize the dependence of Ti on Xi and intercept terms that describe the
baseline distribution of Ti. In addition, we make the strong ignorability of treatment assignment
assumption (Rosenbaum & Rubin, 1983), also known as the unconfoundedness assumption,
pr{Ti | Yi(tP),Xi} = pr(Ti | Xi) where Yi(tP) is a random variable that maps a potential treatment
tP to a potential outcome, and the positivity assumption (Imai & van Dyk, 2004), pr(Ti ∈ A |
Xi) > 0 for all Xi and any set A with positive measure. Finally, the distribution of potential
outcomes for one unit is assumed to be independent of the potential treatment value of another
unit given the set of pretreatment covariates; this is the stable unit treatment value assumption.
Throughout the paper, we make the above assumptions; otherwise our method may result in
severely biased causal effect estimates, even compared with an unadjusted analysis. For example,
when unconfoundedness holds without conditioning on Xi, adjusting for Xi can induce M-bias
(Ding & Miratrix, 2015).
2·2. Covariate selection
We brieﬂy review some methods for covariate selection. When the causal structure is known
and represented by a directed acyclic graph, Shpitser et al. (2010) gave a complete graphical
criterion, the adjustment criterion, to determine whether adjusting for a set of covariates ensures
unconfoundedness. The adjustment criterion generalizes the back-door criterion of Pearl (1995),
which is sufﬁcient but not necessary for unconfoundedness. In the absence of knowledge about
how covariates are causally related to each other, VanderWeele & Shpitser (2011) proposed
the disjunctive cause criterion. This says that if any subset of pretreatment covariates sufﬁces
to ensure unconfoundedness, then the subset of pretreatment covariates that are causes of the
treatment assignment and/or the outcome will also sufﬁce.
Given that an adjustment set that ensures unconfoundedness has been identiﬁed, many
researchers have proposed dimension reduction procedures to increase efﬁciency while main-
taining unconfoundedness (de Luna et al., 2011; VanderWeele & Shpitser, 2011), or to minimize
mean squared error (Vansteelandt et al., 2012). Broadly, these methods tend to remove from the
adjustment set covariates that are unassociated with the outcome.
2·3. Stabilized inverse probability of treatment weighting
A popular approach to causal effect estimation is to weight each unit’s data by stabilized
inverse probability of treatment weights Wi = Wi(Ti,Xi) = pr(Ti)/pr(Ti | Xi) (Robins et al.,
2000). The idea is that if the propensity function is known, the propensity function after weighting
by Wi, pr∗(Ti | Xi), will be equivalent to pr(Ti) and hence does not depend on Xi, as shown
in the Supplementary Material. Here ∗ denotes the pseudo-population after weighting. Under
the assumptions in § 2·1, weighting by Wi also preserves the causal effect of tP on E{Yi(tP)}
in the original population (Robins, 2000; Zhang et al., 2016), and so the causal effect can be
consistently estimated without adjusting for Xi in the weighted data. For example, E{Yi(tP)} can
be consistently estimated by modelling E(Yi | Ti) in the weighted data (Robins, 2000).
2·4. Maximum likelihood estimation
Estimating the weights by maximum likelihood involves specifying parametric models
pr(Ti;α) and pr(Ti | X˜i;β), where X˜i are functionals of elements in Xi, and then estimating
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the unknown parameters α and β by solving the score equations
S(α) =
n∑
i=1
∂
∂α
log pr(Ti;α) = 0, S(β) =
n∑
i=1
∂
∂β
log pr(Ti | X˜i;β) = 0.
If pr(Ti | X˜i;β) and pr(Ti;α) are correctly speciﬁed, then the weights Wi = Wi(Ti, X˜i; αˆ, βˆ) =
pr(Ti; αˆ)/pr(Ti | X˜i; βˆ), where αˆ and βˆ are the maximum likelihood estimates of α and β, are
equivalent to pr(Ti)/pr(Ti | X˜i) asymptotically. Thus weighting by Wi will result in pr∗(Ti | X˜i)
being asymptotically equivalent to pr(Ti), i.e., Ti does not depend on X˜i after weighting. Here
pr∗(Ti | X˜i) depends on αˆ and βˆ through the estimated weights. However, when pr(Ti | X˜i;β)
is misspeciﬁed, this estimation procedure not only will result in pr∗(Ti | X˜i) diverging from
pr(Ti) but also does not even guarantee that the association between X˜i and Ti is reduced in the
weighted data relative to the observed data. Researchers are therefore encouraged to check for
the absence of this association in the weighted data before proceeding to causal effect estimation.
For nonbinary treatments, correctly specifying the propensity function model will generally
also entail correct speciﬁcation of the distribution and the dependence structure on covariates for
higher-order moments of the treatment variable. Therefore, model misspeciﬁcation for nonbinary
treatments is likely to be worse.
3. METHODOLOGY
3·1. General framework
Maximum likelihood estimation indirectly aims to achieve the asymptotic equivalence of
pr∗(Ti | X˜i) and pr(Ti) by ﬁtting a model pr(Ti | X˜i;β) for the propensity function. We instead
propose to use weighting to directly eliminate the association between X˜i and Ti characterized by
a chosen propensity function pr(Ti | X˜i;β) in the weighted data. When pr(Ti | X˜i;β) is misspec-
iﬁed, our method, in contrast to maximum likelihood estimation, will eliminate the association
between X˜i and Ti as characterized by pr(Ti | X˜i;β) after weighting. This is necessary for Ti
to be independent of X˜i after weighting. In the unlikely scenario that pr(Ti | X˜i;β) is correctly
speciﬁed, maximum likelihood estimation will asymptotically eliminate the association between
X˜i and Ti after weighting, while our method will eliminate their association in ﬁnite samples.
We now formalize our ideas. Given a set of known weights W = (W1, . . . ,Wn), we can ﬁt a
parametric propensity function model pr{Ti | X˜i;β(W )} to the data weighted by W by solving
the score equations
n∑
i=1
Wi
∂
∂β(W )
log pr{Ti | X˜i;β(W )} = 0, (1)
where β(W ) is a vector of parameters. Here we write β(W ) as a function of W because the result-
ing maximum likelihood estimates, βˆ(W ), will depend on W .We use the uniquely parameterized
propensity function assumption in § 2·1 to partitionβ(W ) into {βb(W ),βd(W )}, whereβd(W ) are
the unique parameters that characterize the dependence of Ti on X˜i, e.g., regression coefﬁcients,
and βb(W ) are parameters that characterize the baseline distribution, e.g., the intercept terms.
Here the subscripts ‘d’ and ‘b’ stand for dependence and baseline, respectively. Without loss of
generality, we assume pr[Ti | X˜i; {βb(W ),βd(W ) = 0}] = pr{Ti;βb(W )}. The conditions for
covariate association eliminating weights are then derived by inverting (1) such that the weights
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W satisfy the equations
n∑
i=1
Wi
∂
∂β(W )
log pr{Ti | X˜i;β(W )}
∣∣∣{βb(W )=αˆ,βd(W )=0} = 0, (2)
where αˆ is obtained by ﬁtting pr(Ti;α) to the observed data. Our method therefore sets the goal of
weighting as attaining βˆ(W ) = {βˆb(W ) = αˆ, βˆd(W ) = 0}; that is, after weighting by Wi, (i) Ti
is unassociated with X˜i, as described by pr{Ti | X˜i;β(W )}, and (ii) the marginal distribution of Ti
is preserved from the observed data, as described by pr(Ti;α). Here (ii) is a statement concerning
the projection function, the treatment assignment distribution in the weighted data. The choice
of projection function, as long as it does not depend on X˜i, does not affect the consistency of
weighted estimators for causal treatment effects, although it does affect their efﬁciency (Peterson
et al., 2010). In our method, the projection function may be altered by ﬁxing βb(W ) in (2) at
other values instead of αˆ; an example is provided in § 4·1.
Our method is linked to the use of regression to assess covariate balance, for example in
matched data (Lu, 2005). Speciﬁcally, if applying regression to matched data indicates small
associations between the covariates and treatment assignment, it would be reasonable to assume
that the covariate distributions are approximately balanced across treatment levels. Inspired by
this, we propose to invert this covariate balance measure for weight estimation such that it implies
no imbalances in covariate distributions across treatment levels, i.e., βˆd(W ) = 0, after weighting.
3·2. Convex optimization for weight estimation
We consider a convex optimization approach in the spirit of Zubizarreta (2015), intended to
estimate minimum-variance weights subject to the conditions (2) being satisﬁed. We formulate
the estimation problem as a quadratic programming task and use the lsei function in the R (R
Development Core Team, 2018) package limSolve (Soetaert et al., 2009) to obtain the optimal
weights. Speciﬁcally, we solve the following quadratic programming problem for W :
minimize
n∑
i=1
(Wi − 1)2 (3)
subject to
n∑
i=1
Wi
∂
∂β(W )
log pr{Ti | X˜i;β(W )}
∣∣∣{βb(W )=αˆ,βd(W )=0} = 0, (4)
n∑
i=1
Wi = n, Wi  0 (i = 1, . . . , n). (5)
The constraints (4) are the equations (2), and so should eliminate the associations between
covariates and treatment assignment after weighting. They also preserve the marginal distribution
of the treatment variable in the observed data. The ﬁrst constraint in (5) ensures equality of the
numbers of units in the weighted and observed data. Since this also ensures that the mean of W
is unity, (3) minimizes the variance of W . Interestingly, since the weights in the observed data
are ones, (3) can also be interpreted as identifying the least extrapolated data as characterized
by the L2-norm. The second constraint in (5) requires that each element of W be nonnegative
(Hainmueller, 2012; Zubizarreta, 2015).Allowing some elements of W to be zero can let the esti-
mation problem be formulated as a convex quadratic programming problem. Then the estimation
procedure could remove units which contribute greatly to the variability of the weights, while
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forcing the remaining units to allow unbiased estimation of causal treatment effects (Crump et al.,
2009). Following Zubizarreta (2015), it is possible to relax the strict equality constraints (4) to
inequalities; the R function lsei has this option. This allows for less extrapolation at the expense
of possibly introducing bias. For simplicity, we consider only the case where the strict equality
constraints (4) are enforced.
4. RELATION TO PREVIOUS METHODS
4·1. Binary treatment
The moment conditions speciﬁed in existing covariate balancing weight methods (Imai &
Ratkovic, 2014; Fong et al., 2018) are special cases of the conditions (2) after slightmodiﬁcations.
In this section we focus on binary treatments. The details for more general categorical treatments
can be found in the Supplementary Material.
Unless stated otherwise in our derivations, we implicitly take βd(W ) and βb(W ) in (2) to be,
respectively, the vector of regression coefﬁcients of X˜i and the vector of the remaining parameters,
including intercept terms, in the chosen propensity function model.
Let X ∗i = (1, X˜ Ti )T. When Ti is a binary treatment variable, i.e., Ti = 1 if the ith unit received
treatment and Ti = 0 otherwise, the following covariate balancing conditions for the estimation
of the propensity score have been proposed (Imai & Ratkovic, 2014):
1
n
n∑
i=1
WiTiX
∗
i =
1
n
n∑
i=1
Wi(1 − Ti)X ∗i . (6)
Because X ∗i includes 1, these covariate balancing conditions constrain the number of units in the
treated and control groups to be equal in the weighted data. The other conditions for X˜i constrain
the weighted means of each element in X˜i in the treated and control groups to be equal.
These conditions can be derived using our framework. Suppose thatwe specify a logistic regres-
sionmodel for the propensity function/score, pr{Ti = 1 | X˜i;β(W )} = 1/[1+exp{−β(W )TX ∗i }],
in theweighted data induced by a set of knownweightsW . Thismodel can be ﬁtted to theweighted
data by solving the score equations
n∑
i=1
WiX
∗
i
[
Ti − 11 + exp{−β(W )TX ∗i }
]
= 0.
Conditions can be derived by ﬁxing 1/[1 + exp{−β(W )TX ∗i }] = πˆ0, i.e., letting βˆd(W ) = 0, in
these weighted score equations, where πˆ0 is the proportion of units that received treatment in the
observed data, and then inverting these equations so that we are solving for W :
n∑
i=1
WiX
∗
i (Ti − πˆ0) = 0. (7)
The correspondence between (6) and (7) can then be established by changing the projection
function from πˆ0 to 1/2.
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4·2. Continuous treatment
When Ti is continuous on the real line, Fong et al. (2018) proposed the following covariate
balancing conditions for weight estimation,
1
n
n∑
i=1
WiX
∗c
i T
c
i = 0, (8)
where the superscript c denotes the centred version of the variable and X ∗i = (1, X˜ Ti )T. We now
derive these covariate balancing conditions using the proposed framework. First, we assume a
simple normal linear model for the propensity function, Ti | X˜i;β(W ) ∼ N {β(W )TX ∗i , σ 2}. The
score equations for this model in the weighted data are
n∑
i=1
WiX
∗
i
{
Ti − β(W )TX ∗i
σ 2
}
= 0,
n∑
i=1
Wi
[
−1 + {Ti − β(W )
TX ∗i }2
σ 2
]
= 0.
By inverting these score equations, we ﬁnd weights W that satisfy
n∑
i=1
WiX
∗
i
(
Ti − μˆ0
σˆ 20
)
= 0,
n∑
i=1
Wi
{
−1 + (Ti − μˆ0)
2
σˆ 20
}
= 0, (9)
where μˆ0 and σˆ 20 are the sample mean and variance of Ti. The ﬁrst set of conditions in (9) is
equivalent to the conditions (8), except that the X ∗i are not necessarily centred. The usefulness
of our framework can also be exempliﬁed by the insight it gives into how conditions can be
speciﬁed for the variance of Ti. Speciﬁcally, suppose that we specify an alternative propensity
function model Ti | X˜i;βμ(W ),βσ (W ) ∼ N [βμ(W )TX ∗i , exp{2βσ (W )TX ∗i }]; that is, we allow
the variance of Ti, σ 2i , to depend on X˜i with σi = exp{βσ (W )TX ∗i }. For this model, the conditions
for weight estimation are derived by setting the regression coefﬁcient elements in βμ(W ) and
βσ (W ) to zero in the score equations. This corresponds to solving the equations
n∑
i=1
WiX
∗
i
(
Ti − μˆ0
σˆ 20
)
= 0,
n∑
i=1
WiX
∗
i
{
−1 + (Ti − μˆ0)
2
σˆ 20
}
= 0. (10)
Thus, the additional conditions in (10) are designed to remove the association between X˜i and
the variance of Ti. More details can be found in § 6.
5. OTHER TREATMENT TYPES
Having demonstrated that our framework encompasses previously proposed work, we now
widen its applicability by considering semicontinuous treatments, motivated by our application
in § 7. Details about count treatments can be found in the Supplementary Material.
Semicontinuous variables are characterized by a point mass at zero and a right-skewed contin-
uous distribution with positive support (Olsen & Schafer, 2001). Semicontinuous treatments are
common in clinical settings because only treated patients will be prescribed a continuous dose of
treatment; otherwise their dose will be recorded as zero (Moodie & Stephens, 2010). A common
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approach to modelling semicontinuous data is by using a two-part model, such as that in Olsen
& Schafer (2001):
pr(Ti | X˜i;πi,μi, σi) = (1 − πi)I (Ti=0)
[
πi
σi
φ
{
g(Ti) − μi
σi
}]I (Ti>0)
, (11)
where πi = 1/[1 + exp{−βπ(W )TX ∗i }], μi = βμ(W )TX ∗i and σi = exp{βσ (W )TX ∗i } with
X ∗i = (1, X˜ Ti )T, φ(·) is the standard normal density function, and I (·) is an indicator function.
Here g(·) is a monotonic function included to make the normal assumption for the positive values
of Ti more tenable. The likelihoods for the binary and continuous components of the two-part
model are separable, so the results in § 4 imply that the conditions based on (11) are
n∑
i=1
WiX
∗
i {I (Ti > 0) − πˆ0} = 0, (12)
∑
i:Ti>0
WiX
∗
i
{
g(Ti) − μˆ0
σˆ 20
}
= 0,
∑
i:Ti>0
WiX
∗
i
[
−1 + {g(Ti) − μˆ0}
2
σˆ 20
]
= 0, (13)
where πˆ0, μˆ0 and σˆ0 are maximum likelihood estimates of πi, μi and σi obtained by ﬁtting (11),
butwithout covariates, to the observedTi. The conditions (12) are derived from the score equations
for the binary component and are equivalent to (7). The conditions (13) are derived from the score
equations of the continuous component and are similar to (10). In our framework, the weights W
are estimated by solving (12) and (13) simultaneously, whereas maximum likelihood estimation
obtains weightsWbi andWci separately from the binary and continuous components, respectively,
and then uses their unit-speciﬁc product Wi = WbiWci as the ﬁnal weight.
6. SIMULATION STUDY
We consider the set-up where there are three independent standard normal pretreatment covari-
ates X1i, X2i and X3i. The treatment Ti is semicontinuous. We ﬁrst simulate a binary indicator
for Ti > 0 with pr(Ti > 0) = 1/[1 + exp{−(0·5 + X1i + X2i + X3i)}]. Then if Ti > 0, Ti is
drawn from a normal distribution with mean 1+0·5X1i +0·2X2i +0·4X3i and standard deviation
exp(0·3 + 0·3X1i + 0·1X2i + 0·2X3i). The outcome Yi follows a negative binomial distribution
pr(Yi = yi) = (yi + 1/θ)
(1/θ)yi!
(
θλi
1 + θλi
)yi ( 1
1 + θλi
)1/θ
(yi = 0, 1, . . .), (14)
where θ = 1 and λi = E(Yi | Ti,X1i,X2i,X3i) = exp[−1 + 0·5Ti + 2/{1 + exp(−3X1i)} +
0·2X2i − 0·2 exp(X3i)]. Using this set-up, we generate four sets of 2500 simulated datasets with
n = 500, 1000, 2500 and 4000.
For each of the four sets of simulations, we use the proposed method for semicontinuous
treatments in § 5, referred to as Approach 1, and maximum likelihood estimation, referred to as
Approach 2, with the propensity function model (11) to obtain the weights. For both methods
we consider two different model structures and two sets of covariates for the propensity function
model. The correct model structure A allows the mean and variance of Ti conditional on Ti > 0
to depend on covariates, whereas the incorrect model structure B restricts σi to be a constant
σ . The ﬁrst set of covariates are the correct covariates, X˜i = (X1i,X2i,X3i)T, and the second set
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Fig. 1. Plots of the bias (left panels), empirical variance (middle panels) and mean squared error (right panels) of
the treatment effect estimates as a function of sample size, for the correct (top panels) and transformed (bottom
panels) covariate sets; in each panel the different line types represent Approach 1 with model structure A (dotted),
Approach 1 with model structure B (dot-dash), Approach 2 with model structure A (solid), and Approach 2 with
model structure B (dashed).
are transformed covariates of the form X˜i = (X t1i,X t2i,X t3i)T, where X t1i = (1 + X1i + X2i)2,
X t2i = X2i/{1 + exp(X1i)} and X t3i = (X3i)3. The covariates X t1i and X t3i were chosen to be highly
predictive of the outcome. In total, we ﬁt eight models to each simulated dataset to estimate the
weights, which are scaled by their averages so that they sum to n. Then, using the estimated
weights, we ﬁt a weighted negative binomial model (14) to the outcome with the marginal mean
λi = exp(γ0+γ1Ti), where γ0, γ1 and θ are parameters to be estimated. The true causal treatment
effect of interest is γ1 = 0·5.
The left panels of Fig. 1 show that the estimates fromApproach 1 have smaller biases than those
from Approach 2, particularly when the covariates are transformed. In this case, bias increases
with sample size in Approach 2 but not in Approach 1. When the correct model structure A is
used with the correct covariates, Approach 1 has smaller bias than Approach 2, perhaps because
Approach 2 requires the law of large numbers to work well before the associations between
covariates and treatment assignment can be eliminated after weighting.
The middle panels of Fig. 1 present the empirical variances of the treatment effect estimates.
When the correct covariates are used, both approaches have small variances that decrease with
sample size, although Approach 1 is better. Within each approach, estimates from the incorrect
model structureB are less variable than those frommodel structureA, perhaps because theweights
are less variable under model structure B as it has fewer degrees of freedom. The variances under
Approach 1, but not underApproach 2, decreasewith sample sizewhen the transformed covariates
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are used. This behaviour in Approach 2 with the transformed covariates is due to a few sets of
estimated weights exacerbating the extremeness of the tails of the sampling distribution as the
sample size increases; see Robins et al. (2007, pp. 553–4) for more details. Similar phenomena
are observed with the mean squared error.
BecauseApproach 2performs so poorly relative toApproach 1when the transformed covariates
are used, it is difﬁcult to distinguish between the performances of Approach 1 under model
structures A and B in Fig. 1, so we summarize the results here: within Approach 1, estimates
from model structure A have smaller biases but larger variances than estimates from model
structure B. Overall, estimates from model structure A have smaller mean squared errors for
n  1000.
In summary, in all examined scenarios, estimates based on the proposed method have smaller
biases and variances than the maximum likelihood estimates.
7. APPLICATION
Steroids are effective and low-cost treatments for relieving disease activity in patients with
systemic lupus erythematosus, a chronic autoimmune disease that affects multiple organ systems.
However, there is evidence that steroid exposure could be associated with permanent organ
damage that might not be attributable to disease activity. Motivated by a recent study (Bruce et al.,
2015), we aim to estimate the causal dose-response relationship between steroid exposure and
damage accrual shortly after disease diagnosis using data from the Systemic Lupus International
Collaborating Clinics inception cohort.
We focus on 1342 patients who were enrolled between 1999 and 2011 from 32 sites and
had at least two yearly assessments in damage accrual after disease diagnosis. The outcome of
interest Yi is the number of items accrued in the Systemic Lupus International Collaborating
Clinics/American College of Rheumatology Damage Index during the period Oi, deﬁned as
the time interval between the two initial assessments in years. The semicontinuous treatment
variable Ti is the average steroid dose per day in milligrams over the same time period. Based
on clinical inputs, we consider the following pretreatment covariates Xi: the numerical scoring
version of the British Isles Lupus Assessment Group disease activity index (Hay et al., 1993;
Ehrenstein et al., 1995), which was developed according to the principle of physicians’ intentions
to treat; age at diagnosis in years; disease duration in years; and the groups of race/ethnicity and
geographic region.
We consider the model (11) for Ti with g(x) = log(x + 1) to reduce right skewness in the
positive steroid dose. For X˜i, we include the main effects of Xi.We use the same four models as in
the simulations to estimate weights. Further details can be found in the Supplementary Material.
We model Yi with a weighted negative binomial model (14), where for examining the
effect of presence of steroid use on damage accrual we specify λi = E(Yi | Ti; γ0, γ1) =
Oi exp{γ0 + γ1I (Ti > 0)}, and for examining the dose-response relationship we specify
λi = E(Yi | Ti; ξ0, ξ1) = Oi exp{ξ0 + ξ1 log(Ti + 1)}, with γ0, γ1, ξ0, ξ1 and θ parameters to be
estimated. We construct 95% bootstrap percentile conﬁdence intervals for parameter estimates
using 1000 nonparametric bootstrap samples.
The results of the outcome regression models based on four sets of estimated weights are
reported in Table 1. Consistent with current clinical evidence (Bruce et al., 2015), estimates from
all weighted outcome regression models indicate that steroid use and the average steroid dose are
positively and signiﬁcantly associated with damage accrual in the initial period following diag-
nosis, although the estimated effect sizes fromApproach 1 are larger than those fromApproach 2.
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Table 1. Parameter estimates and 95% conﬁdence intervals from ﬁtting the weighted outcome
regression models to the systemic lupus erythematosus data
Approach 1 Approach 2
Model structure A Model structure B Model structure A Model structure B
Binary treatment
γ0 −2·50 (−2·93, −2·19) −2·50 (−2·93, −2·18) −2·36 (−2·87, −1·98) −2·36 (−2·87, −1·98)
γ1 0·76 (0·41, 1·21) 0·73 (0·37, 1·19) 0·57 (0·10, 1·10) 0·57 (0·12, 1·10)
θ 1·60 (0·77, 2·53) 1·62 (0·83, 2·54) 1·30 (0·38, 2·48) 1·19 (0·23, 2·41)
Semicontinuous treatment
ξ0 −2·57 (−2·93, −2·29) −2·54 (−2·88, −2·27) −2·47 (−2·89, −2·11) −2·45 (−2·84, −2·12)
ξ1 0·40 (0·24, 0·56) 0·37 (0·23, 0·52) 0·33 (0·16, 0·52) 0·32 (0·15, 0·49)
θ 1·41 (0·70, 2·27) 1·48 (0·75, 2·32) 1·17 (0·34, 2·22) 1·11 (0·28, 2·14)
Approach 1 also yields narrower conﬁdence intervals than Approach 2. Within each approach,
model structure B gives slightly smaller standard errors than model structure A.
We also ﬁtted models with I (Ti > 0) and I (Ti > 0) log(Ti + 1) included in the outcome
regression. This provides the dose-response relationship after removing the patients unexposed
to steroids (Greenland & Poole, 1995). The estimated dose-response functions were similar to
those obtained from the models that include the semicontinuous treatment.
Overall, our results suggest that steroid dose is related to the damage accrual rate at the early
disease stage of systemic lupus erythematosus. This suggests that clinicians might need to seek
steroid-sparing therapies even at the early disease stage in order to reduce damage accrual.
8. LONGITUDINAL SETTING
Our framework can be extended to the longitudinal setting. Here we give an example using a
similar setting to that in Moodie & Stephens (2010). Suppose that for the ith unit (i = 1, . . . , n),
in each time interval [sij−1, sij) ( j = 1, . . . ,mi; si0 = 0) of a longitudinal study, we observe
in chronological order a vector of covariates Xij, a time-varying treatment Tij that can be of
any distribution, and a longitudinal outcome Yij. The units are not necessarily followed up at the
same time-points. Let the random variable Yij(tPij) be the potential outcome that would have arisen
had treatment tPij been administered in the time interval [sij−1, sij). We consider the setting where
interest lies in estimating the direct causal effect of tPij on E{Yij(tPij)}, which may be confounded by
histories of covariates, treatment assignment and response, X¯ij, T¯ij−1 and Y¯ij−1. Here an overbar
represents the history of a process; for example, X¯ij = (Xi1, . . . ,Xij).
In order to identify the direct causal effect of tPij on E{Yij(tPij)}, we make the sequential ignor-
ability assumption, pr{Tij | Yij(tPij), X¯ij, T¯ij−1, Y¯ij−1} = pr(Tij | X¯ij, T¯ij−1, Y¯ij−1) for any time
interval, and the positivity assumption, pr(Tij ∈ A | X¯ij, T¯ij−1, Y¯ij−1) > 0 for all X¯ij, T¯ij−1 and
Y¯ij−1 and for any set A with positive measure. Under these assumptions, the effect of tPij on
E{Yij(tPij)} can be consistently estimated by weighting the ith unit’s data in the interval [sij−1, sij)
with Wij = pr(Tij)/pr(Tij | X¯ij, T¯ij−1, Y¯ij−1) for all units and time intervals. The weights are
typically estimated by Wij = pr(Tij; αˆ)/pr(Tij | X˜ij; βˆ), where X˜ij are functionals of X¯ij, T¯ij−1
and Y¯ij−1, and αˆ and βˆ are the maximum likelihood estimates of α and β.
An alternative approach to weight estimation is to generalize our proposed method. Follow-
ing the same strategy as in § 3·1, we assume that given known weights Wij, the time-varying
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propensity function in the time interval [sij−1, sij) follows a model pr{Tij | X˜ij;β(W )}. As in
§ 3·1, we partition β(W ) into {βb(W ),βd(W )}, where βd(W ) are regression coefﬁcients that
characterize the association between X˜ij and Tij over time, and βb(W ) are parameters that char-
acterize the baseline distribution, e.g., the intercept terms. Similarly to before, conditions for
weight estimation can be derived by inverting the weighted score equations
n∑
i=1
mi∑
j=1
Wij
∂
∂β(W )
log pr{Tij | X˜ij;β(W )}
∣∣∣{βb(W )=αˆ,βd(W )=0} = 0, (15)
where αˆ is obtained by ﬁtting the model pr(Tij;α) to the observed data for the time-varying
treatment Tij. Thus these conditions are designed to eliminate the association between X˜ij and
Tij and to preserve the observed marginal distribution of Tij after weighting. Other projection
functions that can help to further stabilize the weights, such as those that depend on some of the
covariates, can also be considered in the proposed frameworkwith onlyminormodiﬁcations. This
would be useful when the interactions between these covariates and treatment are of interest in
the outcome regression model. Finally, the convex optimization approach in § 3·2 can be used for
weight estimation by replacing the equations (4) with (15). For large sample sizes, a parametric
approach to solving the conditions (15) would be useful.
9. DISCUSSION
The proposed method has some limitations. First, both our method and existing covariate
balancing weight methods treat covariates equally and balance them simultaneously. This can
lead to poor performance in high-dimensional settings, so it would be of interest to incorporate
different weights for the covariates when estimating the weights for the units. Second, it can be
hard to detect near violations of the positivity assumption with our method, because it generally
results in small variance of the causal effect estimates by exactly balancing the covariates. In
such circumstances, e.g., when there is strong confounding, the results from our method can hide
the fact that the observed data alone carry little information about the target causal effect and
can have large bias under model misspeciﬁcation because our method will almost entirely rely
on extrapolation. It is therefore important to assess the positivity assumption when applying our
framework. Third, ourmethod does not necessarily estimate the causal effect for the population of
interest, such as the target population of a health policy. This can be remedied by supplementing
the conditions (4) with the additional conditions
∑n
i=1 WiX˜i/n = c, where c is the sample mean
of X˜i with respect to the target population (Stuart et al., 2011).
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